[go: up one dir, main page]

NO20080323L - Compounds and their salts specific to PPAR receptors and EGF receptors and their use in medicine - Google Patents

Compounds and their salts specific to PPAR receptors and EGF receptors and their use in medicine

Info

Publication number
NO20080323L
NO20080323L NO20080323A NO20080323A NO20080323L NO 20080323 L NO20080323 L NO 20080323L NO 20080323 A NO20080323 A NO 20080323A NO 20080323 A NO20080323 A NO 20080323A NO 20080323 L NO20080323 L NO 20080323L
Authority
NO
Norway
Prior art keywords
receptors
medicine
compounds
atoms
linear
Prior art date
Application number
NO20080323A
Other languages
Norwegian (no)
Inventor
Giancarlo Naccari
Sergio Baroni
Original Assignee
Giuliani Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Int Ltd filed Critical Giuliani Int Ltd
Publication of NO20080323L publication Critical patent/NO20080323L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/64—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

Foreliggende oppfinnelse angår spesifikt forbindelser med den generelle formel (I): (I) hvor R1 og R2, som kan være like eller forskjellige, er valgt fra gruppen omfattende H, -CnH2n-1, en lineær eller forgrenet alkylgruppe som har fra 1 til 6 karbonatomer eller sammen danner en aromatisk eller alifatisk ring med 5 eller 6 atomer; R3 er valgt fra -CO-CH3, -NHOH, -OH, -OR6, hvor R6 er en lineær eller forgrenet alkylgruppe som har fra 1 til 6 karbonatomer; R4 er valgt fra H, en lineær eller forgrenet alkylgruppe som har fra 1 til 6 karbonatomer, fenyl, benzyl, -CF3 eller -CF2CF3, vinyl eller allyl; R5, R7, R8 er hydrogenatomer; eller R3 og R4, R4 og R5 eller R7 og R8 danner sammen en ring, kondensert til benzenet, aromatisk eller alifatisk ring med 5 eller 6 atomer omfattende fra 1 til 2 heteroatomer uavhengig valgt fra gruppen omfattende N, O, og anvendelse derav innen medisin.The present invention specifically relates to compounds of the general formula (I): (I) wherein R 1 and R 2, which may be the same or different, are selected from the group comprising H, -Cn H 2 n-1, a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring of 5 or 6 atoms; R 3 is selected from -CO-CH 3, -NHOH, -OH, -OR 6, where R 6 is a linear or branched alkyl group having from 1 to 6 carbon atoms; R 4 is selected from H, a linear or branched alkyl group having from 1 to 6 carbon atoms, phenyl, benzyl, -CF 3 or -CF 2 CF 3, vinyl or allyl; R5, R7, R8 are hydrogen atoms; or R3 and R4, R4 and R5 or R7 and R8 together form a ring condensed to the benzene, aromatic or aliphatic ring of 5 or 6 atoms comprising from 1 to 2 heteroatoms independently selected from the group comprising N, O, and use thereof in medicine .

NO20080323A 2005-07-22 2008-01-18 Compounds and their salts specific to PPAR receptors and EGF receptors and their use in medicine NO20080323L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000390A ITRM20050390A1 (en) 2005-07-22 2005-07-22 COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
PCT/IE2006/000076 WO2007010514A2 (en) 2005-07-22 2006-07-24 Compounds and their salts specific to the ppar receptors and the egf receptors and their use in the medical field

Publications (1)

Publication Number Publication Date
NO20080323L true NO20080323L (en) 2008-04-15

Family

ID=37574984

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080323A NO20080323L (en) 2005-07-22 2008-01-18 Compounds and their salts specific to PPAR receptors and EGF receptors and their use in medicine

Country Status (11)

Country Link
US (2) US8138357B2 (en)
EP (1) EP1910275B1 (en)
JP (1) JP5193862B2 (en)
CN (1) CN101243043B (en)
AU (1) AU2006271163B2 (en)
BR (1) BRPI0613398A2 (en)
CA (1) CA2615978A1 (en)
IT (1) ITRM20050390A1 (en)
NO (1) NO20080323L (en)
NZ (1) NZ566044A (en)
WO (1) WO2007010514A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
ITRM20050390A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
IE20070129A1 (en) * 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
ITMI20072429A1 (en) 2007-12-24 2009-06-25 Giuliani Int Ltd COMPOUNDS FOR THE SELECTIVE TREATMENT OF THE INTESTINAL IMMUNE-INFLAMMATORY COMPONENT OF THE CELIAC DISEASE
UA107562C2 (en) * 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
BRPI1011226B1 (en) 2009-02-16 2019-10-29 Giuliani Internacional Ltd use of a pharmaceutical composition to treat hair related conditions
CN109999017A (en) * 2012-02-09 2019-07-12 诺格拉制药有限公司 The method for treating fibrosis
CA2870490A1 (en) 2012-04-18 2013-10-24 Nogra Pharma Limited Methods of treating lactose intolerance
US10029995B2 (en) 2015-09-03 2018-07-24 Forma Therapeutics, Inc. [6,6] fused bicyclic HDAC8 inhibitors
WO2020152350A1 (en) 2019-01-25 2020-07-30 Nogra Pharma Limited Compositions for use in preventing acne
DK3921299T3 (en) 2019-02-08 2025-01-27 Nogra Pharma Ltd PROCESS FOR THE PRODUCTION OF 3-(4'-AMINOPHENYL)-2-METHOXYPROPIONIC ACID AND ITS ANALOGUES AND INTERMEDIATES
WO2025132838A1 (en) 2023-12-20 2025-06-26 Nogra Pharma Limited Acne topical formulations

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
US3211610A (en) * 1961-09-29 1965-10-12 Merck & Co Inc Benzoic acid ester derivatives for treating coccidiosis and method of using same
US3444232A (en) * 1966-05-18 1969-05-13 Squibb & Sons Inc O-alkyl or phenylalkyl benzohydroxamic acids
US4036951A (en) * 1973-03-12 1977-07-19 Synergistics, Inc. Ultra-violet filtration with certain aminosalicylic acid esters
GB1561350A (en) * 1976-11-05 1980-02-20 May & Baker Ltd Benzamide derivatives
EP0055689B1 (en) 1980-12-22 1984-07-04 Schering Aktiengesellschaft 3-substituted 2,4,6-trihalogenobenzamides and their salts, their preparation and their use as substitutes for natural sweetening agents, and sweeteners containing them
IL69282A (en) * 1982-09-02 1988-06-30 Euro Celtique Sa Method for the carboxylation of potassium phenoxide with carbon dioxide
NZ224087A (en) * 1987-04-01 1990-08-28 Dak Lab As Topical pharmaceutical compositions containing 4- or 5- amino salicylic acid or a functional derivative thereof
DE68919009T2 (en) 1988-05-05 1995-02-23 Tillotts Pharma Ag Use of 5-amino-salicylic acid for the treatment of skin diseases.
US5519014A (en) * 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
US5262549A (en) * 1991-05-30 1993-11-16 Polaroid Corporation Benzpyrylium dyes, and processes for their preparation and use
US5302751A (en) * 1992-01-21 1994-04-12 Ethyl Corporation Profen resolution
AU674330B2 (en) 1992-06-30 1996-12-19 Howard K. Shapiro Composition containing amine and amine-related derivatives of benzoic acid and uses therefor including treating inflammatory diseases
KR100243535B1 (en) * 1992-07-17 2000-03-02 디르크 반테 4-amino-N- (4-methyl-4-piperidinyl) -2-methoxybenzamide (4-amino-N- (4-methyl-4-piperidinyl) -2-methoxybenzamides)
US5594151A (en) * 1994-01-28 1997-01-14 Prolinx, Inc. Phenylboronic acid complexing reagents derived from aminosalicylic acid
WO1995031194A1 (en) 1994-05-11 1995-11-23 Shapiro Howard K Compositions for treatment of chronic inflammatory diseases
US5939442A (en) * 1995-06-07 1999-08-17 The Salk Institute For Biological Studies Modulations of peroxisome proliferator activated receptor-γ, and methods for the use thereof
GB9600464D0 (en) * 1996-01-09 1996-03-13 Smithkline Beecham Plc Novel method
GB9617001D0 (en) 1996-08-13 1996-09-25 Tillotts Pharma Ag Oral composition
DE19647582A1 (en) * 1996-11-18 1998-05-20 Hoechst Ag Process for the preparation of aromatic olefins by means of catalysis by palladaphosphacyclobutanes
AU6773598A (en) 1997-03-26 1998-10-20 Institut Pasteur Treatment of gastrointestinal disease with ppar modulators
US7098025B1 (en) * 1997-07-25 2006-08-29 Ligand Pharmaceuticals Incorporated Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor
WO1999015520A1 (en) * 1997-09-19 1999-04-01 Ono Pharmaceutical Co., Ltd. Fused or nonfused benzene compounds
US6326364B1 (en) * 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
FR2791671B1 (en) 1999-04-01 2001-05-11 Oreal NOVEL COMPOUNDS DERIVED FROM BENZOIC ACID ESTERS, COMPOSITION COMPRISING SAME AND USE THEREOF
US20040034067A1 (en) * 1999-04-15 2004-02-19 Macphee Colin Houston Novel method of treatment
GB9914371D0 (en) * 1999-06-18 1999-08-18 Smithkline Beecham Plc Novel compounds
ES2226818T3 (en) 2000-04-19 2005-04-01 Neurotech Co., Ltd. COMPOUNDS, COMPOSITIONS AND METHODS TO PREVENT CHRONIC NEURODEGENERATION AND DAMAGE IN THE CENTRAL NERVOUS SYSTEM.
ATE407919T1 (en) 2000-05-29 2008-09-15 Kyorin Seiyaku Kk SUBSTITUTED PHENYLPROPIONIC ACID DERIVATIVES
EP1642885B1 (en) 2000-08-29 2009-11-11 Biocon Limited Use of a pharmaceutical composition containing a para-aminophenyl acetic acid derivative for treating inflammatory conditions of the gastrointestinal tract
CA2430846A1 (en) 2000-12-05 2002-06-13 Kyorin Pharmaceutical Co., Ltd. Substituted carboxylic acid derivatives
FR2822955B1 (en) * 2001-03-27 2003-10-03 Chru Lille METHOD FOR DIAGNOSING CHRONIC INFLAMMATORY BOWEL DISEASES
CA2354921A1 (en) * 2001-05-24 2002-11-24 Yasuo Konishi Drug evolution: drug design at hot spots
CA2463685A1 (en) 2001-10-16 2003-04-24 Dr. Reddy's Laboratories Ltd. Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds
GB0127916D0 (en) * 2001-11-21 2002-01-16 Rowett Res Inst Method
UA82835C2 (en) * 2001-12-03 2008-05-26 Reddys Lab Ltd Dr ?-aryl-?-oxysubstituted propionuc acid derivatives and pharmaceutical composition based thereon
US20030113815A1 (en) * 2001-12-19 2003-06-19 Pfizer Inc. Canine peroxisome proliferator activated receptor gamma
US20030220374A1 (en) 2002-01-14 2003-11-27 Pharmacia Corporation Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
US20040115127A1 (en) * 2002-04-12 2004-06-17 Wright Samuel D. Ppar-alpha-gamma ligands or agonists for the treatment of inflammation
GB0303609D0 (en) 2003-02-17 2003-03-19 Glaxo Group Ltd Novel therapeutic method and compositions
JPWO2004082715A1 (en) * 2003-03-20 2006-06-22 エーザイ株式会社 Concomitant medications as therapeutic agents for inflammatory bowel disease
JP5198768B2 (en) * 2003-07-21 2013-05-15 メルク セローノ ソシエテ アノニム Alkynylarylcarboxamide
ATE526964T1 (en) * 2003-07-21 2011-10-15 Merck Serono Sa ARYL-DICARBONIC ACID DIAMIDES
EP1722630A4 (en) 2004-01-20 2009-05-27 Richard F Harty COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES
WO2005084658A1 (en) 2004-03-04 2005-09-15 Arakis Ltd. Derivatives of actarit and their therapeutic use
US20060286046A1 (en) 2005-01-05 2006-12-21 Haber C Andrew Skin care compositions
US20060270635A1 (en) * 2005-05-27 2006-11-30 Wallace John L Derivatives of 4- or 5-aminosalicylic acid
ITRM20050390A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
ITRM20050389A1 (en) 2005-07-22 2007-01-23 Giuliani Spa COMPOUNDS AND THEIR SPECIFIC SALTS FOR PPAR RECEPTORS AND RECEPTORS FOR EGF AND THEIR USE IN MEDICAL FIELDS.
DE102005061472A1 (en) * 2005-12-22 2007-07-05 Saltigo Gmbh Process for the preparation of enantiomerically enriched 2-alkoxy-3-phenylpropionic acids
IE20070129A1 (en) 2007-02-28 2008-12-24 Giuliani Int Ltd Ppar-gamma agonists stimulate enteric defensin expression
ITMI20072429A1 (en) 2007-12-24 2009-06-25 Giuliani Int Ltd COMPOUNDS FOR THE SELECTIVE TREATMENT OF THE INTESTINAL IMMUNE-INFLAMMATORY COMPONENT OF THE CELIAC DISEASE
UA107562C2 (en) 2008-12-05 2015-01-26 METHOD OF TREATMENT OF PSORIASIS
BRPI1011226B1 (en) 2009-02-16 2019-10-29 Giuliani Internacional Ltd use of a pharmaceutical composition to treat hair related conditions

Also Published As

Publication number Publication date
CN101243043B (en) 2013-03-20
AU2006271163A1 (en) 2007-01-25
JP5193862B2 (en) 2013-05-08
NZ566044A (en) 2012-06-29
EP1910275B1 (en) 2013-02-13
EP1910275A2 (en) 2008-04-16
CN101243043A (en) 2008-08-13
ITRM20050390A1 (en) 2007-01-23
WO2007010514A3 (en) 2007-03-29
AU2006271163B2 (en) 2012-03-15
US8450506B2 (en) 2013-05-28
WO2007010514A2 (en) 2007-01-25
JP2009502775A (en) 2009-01-29
US8138357B2 (en) 2012-03-20
US20090118357A1 (en) 2009-05-07
BRPI0613398A2 (en) 2011-01-11
US20120316230A1 (en) 2012-12-13
CA2615978A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
NO20080323L (en) Compounds and their salts specific to PPAR receptors and EGF receptors and their use in medicine
NO20080325L (en) Compounds and their salts specific to PPAR and EGF receptors as well as their use in medicine
NO20076498L (en) Derivatives of 4- (2-amino-1-hydroxyethyl) phenol as agonists of the beta2-adrenergic receptor
AR052866A1 (en) SUBSTITUTED MONOCICLIC PHENYL-METANONES
NO20080942L (en) Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of beta-secretase (BACE)
EA201101089A1 (en) OXADIAZOLE DERIVATIVES AS AN AGONISTS OF S1P1 RECEPTOR
UA107672C2 (en) N-(1,2,5-oxadiazol-3-yl)benzamides and the use thereof as herbicides
NO20092770L (en) Novel aminopyrimidine derivatives as PLK1 inhibitors
PE20061490A1 (en) CYCLOHEXANOSULPHONYL DERIVATIVES AS INHIBITORS OF THE GLYCINE TRANSPORTER GLYT1
MY142807A (en) Benzimidazole derivative and use thereof.
CO6241076A2 (en) BENZAMIDA COMPOUNDS AND APPLICATIONS OF THE SAME
ATE388146T1 (en) 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBONIC ACID AMIDE DERIVATIVES WITH AGONISTIC EFFECT ON THE 5-HT4 RECEPTOR
CY1120477T1 (en) Receiver-actuator actuator actuated by sub-multipliers
PH12015501098A1 (en) Antituberculous composition comprising oxazole compounds
MX2010002938A (en) (3-hydroxy-4-amino-butan-2-yl) -3- (2-thiazol-2-yl-pyrrolidine-1- carbonyl) benzamide derivatives and related compounds as beta-secretase inhibitors for treating.
TW200704640A (en) Pyrazolecarboxamides
NO983493L (en) New benzimidazole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing such
EA200600878A1 (en) PHENOXYACIC ACID DERIVATIVES APPLICABLE AS A DOUBLE AGONISTS ACTIVATED BY A PEROXYSOMIC PROTECTOR (PPAR)
IN2009KN04279A (en)
EP1961734A4 (en) AMINO COMPOUND AND USE THEREOF FOR MEDICAL APPLICATIONS
NO20063944L (en) Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
CL2009001146A1 (en) Compounds derived from 5- (5- (2- (3,5-bis (trifluoromethyl) phenyl) -n, 2-dimethylpropanoamide) -4- (4-fluoro-2-methylphenyl) pyridin-2-yl) pyrrolidin-2 -carboxamide, nk-1 receptor antagonists; pharmaceutical composition; and use of the compound for the treatment of depression; anxiety, sleep disorders, or emesis.
GEP20115309B (en) Acid addition salts, hydrates and polymorphs of 5-(2,4-dihy-droxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-arboxylic acid ethylamide and formulations comprising these forms
AR054341A1 (en) SYNERGIC COMBINATIONS OF FUNGICIDAL ACTIVE COMPOUNDS
HRP20080538T3 (en) Aryloxyethylamine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application